‘My Heart Was Racing’: JD Vance Talks Stance on COVID Vaccine and His Rough Experience After Taking It

This one nurse friend I met two years ago mocked me for not getting vaxxed. Joked about horse paste when I spoke of Ivermectin. Today after having had covid multiple time, she and her husband rarely go out because they are afraid they will it again. If I were to guess, they probably got the most recent Vax. I worry that the reason so many people in my family are now having medical issues is the vax. One has dementia, one has cancer, one just got ulcertative colitis, one looks like he has aged ten years in the past twi months, sudden onset of high blood pressure, another one has dementia. Hopefully, I’m just experiencing a random personal experience, but I worry the uptick is real.
_____________________________
As we age, illness awaits us all, but the relatively suddenness of the maladies you describe causes any discerning individual to wonder if the vaxx had something to do with it. This relationship is increased by the fact that there is now an illness associated with the vaxx called VAIDS, which has turned up following the injections. VAIDS is really an acronym for a vaxx induced compromised immune system. Toxins shot directly into us bypass and damage the body. We all know our natural immune system is the guardian of our overall well being. Some many years ago, I got a bad case of shingles when my wife was in Johns Hopkins with pancreatitis and almost died. I’m convinced that the stress of that event weakened my immune system just enough for that lousy latent herpes zoster/chicken pox virus to rear its ugly head and give me a painful case of shingles. Keeping our natural immune system working at 100% is the best insurance we have for a healthy and long life. We only need look to the Amish people and their life style for answers on how to live a healthy and long life. Bobby Kennedy will hopefully work to straiten this mess out.
https://www.naturalnews.com/2023-07-07-zero-amish-kids-suffering-cancer-diabetes-autism.html

Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing over the rights to sell the shot to French drugmaker Sanofi (SASY.PA),

opens new tab.
Shares of the U.S. biotech firm fell 3% to $8.73.
The U.S. vaccine maker now expects between $175 million and $225 million for full-year sales of its COVID vaccine, its only product on the market, down from the $275 million to $375 million it previously forecast.

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.